Literature DB >> 18760652

[Experience feed back committee in radiotherapy (CREx): a compulsory tool for security management evaluation at two years].

E Lartigau1, B Coche-Dequeant, V Dumortier, S Giscard, T Lacornerie, A Lasue, V Cheval, V Martel, B Malfait, A Fuchs, M Pestel, M Damman, M Forrest.   

Abstract

After working on treatment organisation in radiotherapy (bonne pratiques organisationnelles en radiothérapie - action pilote MEAH 2003), the development of a security policy has become crucial. With the help of Air France Consulting and the MEAH, three cancer centers in Angers, Lille and Villejuif worked together on the implantation of experience feed back committees (CREx) dedicated to the registration, analysis and correction of precursor events. After two years, we report the centre Oscar-Lambret experience in Lille and try to get the recommendations for generalisation of the process. This seems now to be compulsory for security management in oncology.

Entities:  

Mesh:

Year:  2008        PMID: 18760652     DOI: 10.1016/j.canrad.2008.07.007

Source DB:  PubMed          Journal:  Cancer Radiother        ISSN: 1278-3218            Impact factor:   1.018


  3 in total

1.  Interprofessional safety reporting and review of adverse events and medication errors in critical care.

Authors:  Claire Chapuis; Sébastien Chanoine; Laurence Colombet; Silvia Calvino-Gunther; Caroline Tournegros; Nicolas Terzi; Pierrick Bedouch; Carole Schwebel
Journal:  Ther Clin Risk Manag       Date:  2019-04-02       Impact factor: 2.423

2.  Experience Feedback Committee: a management tool to improve patient safety in mental health.

Authors:  Thierry Bougerol; Olivier Detante; Arnaud Seigneurin; Patrice François; Bastien Boussat
Journal:  Ann Gen Psychiatry       Date:  2015-09-03       Impact factor: 3.455

3.  Experience feedback committee in emergency medicine: a tool for security management.

Authors:  André Lecoanet; Elodie Sellier; Françoise Carpentier; Maxime Maignan; Arnaud Seigneurin; Patrice François
Journal:  Emerg Med J       Date:  2013-08-20       Impact factor: 2.740

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.